Logo

Jubilant Integrates PathArt Database with FDA s Microarray Analysis Platform

Aug 10, 2004

NEW YORK, Aug. 10 (GenomeWeb News) - Jubilant Biosys said today that it has integrated PathArt, a database of over 900 signaling and metabolic pathways curated manually from the literature, with the US Food and Drug Administration's ArrayTrack DNA microarray analysis software system.

 

"The integration will allow users of ArrayTrack to use the built in plug-in to ... map the results of their analysis within ArrayTrack onto the pathways in PathArt," Sreenivas Devidas, vice president of business development and strategy at Jubilant, said in a statement. "The integration will allow the scientist to view the relevant hits in diseases, physiologies, and individual pathways, and [the] prioritization of targets for further research."

 

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.